Stay updated on Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a software/backend update. No visible study details or eligibility criteria appear to be changed.
    Difference
    0.1%
    Check dated 2026-05-14T23:15:26.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    A new revision tag v3.5.3 was added and the previous v3.5.2 tag removed, signaling an updated version of the study record.
    Difference
    0.1%
    Check dated 2026-04-30T16:27:52.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a backend/software version update and does not modify the study details or page content.
    Difference
    0.1%
    Check dated 2026-04-16T10:07:18.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0; the previous Revision: v3.4.3 label was removed.
    Difference
    0.1%
    Check dated 2026-03-25T20:31:47.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2; no user-facing content changes detected.
    Difference
    0.1%
    Check dated 2026-03-11T15:48:53.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    Publications section added with a cited Oncoimmunology article and a note that these items are auto-filled from PubMed. This contextual information does not alter the trial details, eligibility criteria, or study design on the page.
    Difference
    0.3%
    Check dated 2026-03-04T11:33:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Melanoma: Clinical Trial page.